Literature DB >> 20853310

Increase in the duration of antidepressant treatment from 1994 to 2003: a nationwide population-based study from Finland.

Sinikka Sihvo1, Kristian Wahlbeck, Alison McCallum, Tiina Sevon, Martti Arffman, Jari Haukka, Ilmo Keskimäki, Elina Hemminki.   

Abstract

OBJECTIVE: We examined the length and continuity of antidepressant treatment and factors associated with long-term of treatment among adults.
METHODS: Nationwide data from all reimbursed antidepressant prescriptions in 1994-2003 were linked with patients' data retrieved from Statistics Finland and the Finnish Hospital Discharge Register. Logistic regression models were used to analyse long term use of antidepressants.
RESULTS: The annual prevalence of antidepressant use increased from 3.6% in 1994 to 7.3% in 2003. Short-term use (<3 months) decreased from 58% in 1995 to 51% in 2000 and long-term treatment (≥12 months) increased from 18 to 21%. In 2000, 31% of treatment periods lasted ≥6 months and 24% ≥9 months. Long-term treatment correlated to the purchase of other psychotropics, in-patient psychiatric care, and prescription by a psychiatrist.
CONCLUSIONS: Treatment periods with antidepressants have become longer over time. Clinical factors related to mental disorder severity predict long-term use. Only a quarter had the treatment duration recommended by clinical guidelines for depression.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20853310     DOI: 10.1002/pds.2017

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  7 in total

1.  Methods for constructing treatment episodes and impact on exposure-outcome associations.

Authors:  Laura Pazzagli; Lena Brandt; Marie Linder; David Myers; Panagiotis Mavros; Morten Andersen; Shahram Bahmanyar
Journal:  Eur J Clin Pharmacol       Date:  2019-11-22       Impact factor: 2.953

2.  Trends in the use of antidepressants among older adults: Bambuí Project.

Authors:  Antônio Ignácio de Loyola Filho; Érico Castro-Costa; Josélia Oliveira Araújo Firmo; Sérgio Viana Peixoto
Journal:  Rev Saude Publica       Date:  2014-12       Impact factor: 2.106

3.  Treatment received and treatment adequacy of depressive disorders among young adults in Finland.

Authors:  Teija Kasteenpohja; Mauri Marttunen; Terhi Aalto-Setälä; Jonna Perälä; Samuli I Saarni; Jaana Suvisaari
Journal:  BMC Psychiatry       Date:  2015-03-11       Impact factor: 3.630

Review 4.  Methods for time-varying exposure related problems in pharmacoepidemiology: An overview.

Authors:  Laura Pazzagli; Marie Linder; Mingliang Zhang; Emese Vago; Paul Stang; David Myers; Morten Andersen; Shahram Bahmanyar
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-12-28       Impact factor: 2.890

5.  Influences on antidepressant prescribing trends in the UK: 1995-2011.

Authors:  Becky Mars; Jon Heron; David Kessler; Neil M Davies; Richard M Martin; Kyla H Thomas; David Gunnell
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2016-11-24       Impact factor: 4.328

6.  Learning to experience side effects after antidepressant intake - Results from a randomized, controlled, double-blind study.

Authors:  Julia Rheker; Alexander Winkler; Bettina K Doering; Winfried Rief
Journal:  Psychopharmacology (Berl)       Date:  2016-11-02       Impact factor: 4.530

Review 7.  Barriers to discontinuing antidepressants in patients with depressive and anxiety disorders: a review of the literature and clinical recommendations.

Authors:  Willemijn Scholten; Neeltje Batelaan; Anton Van Balkom
Journal:  Ther Adv Psychopharmacol       Date:  2020-06-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.